India Pharma Outlook
The New India Express
Money Control
Business Standards
Business Standards
The Echo of India
12-07-2021
Satellite Samachar
12-07-2021
Gujarat Pranam
12-07-2021
Ahmedabad Express
12-07-2021
Divya Gujarat
Morepen - The Future of Home Diagnostics and OTC Health Products
India Pharma Outlook
Dr. Morepen launches advanced Muscle Food to fuel your performance
The Pharma Times
Dr. Morepen launches advanced Pre-workout Muscle Food to fuel your performance
Business Gujarat News
Dr. Morepen launches advanced Muscle Food to fuel your performance
Online Media Café
Dr. Morepen launches advanced Muscle Food to fuel your performance
Business News This Week
Dr. Morepen launches advanced Muscle Food to fuel your performance
Business News This Week
Dr. Morepen launches advanced Muscle Food to fuel your performance
Business News Week
Dr. Morepen launches advanced Muscle Food to fuel your performance
Content Media Solution
Morepen Labs introduces advanced muscle food
Nuffoods Spectrum
Dr. Morepen launches advanced muscle food
Indian Pharma Post
Morepen gets USFDA Approval for Fexofinadine (Allegra)
Bengal Editor
Morepen gets USFDA nod for anti-allergy drug
The Health Master
Morepen Labs anti-allergy drug Fexofinadine gets USFDA approval
Medical Dialogues
Morepen gets USFDA Approval for Fexofinadine
ET Health World
This news turns out to be a lucky charm for Morepen Laboratories; read to find out more!
Dalal Street Investment Journal
Morepen gets USFDA nod to market generic anti-allergy drug Fexofinadine Hydrochloride
The New India Express
Morepen Laboratories receives USFDA approval
Economic Times
Morepen Laboratories gets USFDA nod for Fexofinadine
Money Control
Morepen Laboratories gets USFDA nod to market generic anti-allergy drug
Business Standards
Morepen gets USFDA nod to market generic anti-allergy drug
The Economic Times
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
Sachcha Dost
Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore
The Economic Times
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
Devdiscourse
Morepen Labs Q2 net profit up 38 pc to Rs 37 crore
Zee Business
: Morepen Labs Q2 Results: Net Profit Up 38%
ET Health World
Morepen Labs Q2 Results: Net Profit Up 38%
BW Healthcare
Morepen Laboratories Q2
Money Control
Morepen records 70 percent increase in Profit before tax in Q2 with consolidated revenue growth of 17%
Financial Express Health Care
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
Press Trust of India
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
Hari Bhoomi, Delhi
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
Satellite Samachar, Ahmedabad
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
Prabhat, Ahmedabad
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
Divya Gujarat
Morepen records 70% increase in profit before tax in Q2
Western Times, Ahmedabad
Morepen Labs Q2 net profit up 38 %
The Hans India, Delhi
Morepen Labs Q2 net profit up 38 pc to Rs 37 cr
The Pioneer, Hyderabad
Morepen shareholders approve new unit to house medical device biz
The Economic Times
Morepen Lab carves out its Medical Devices into a Subsidiary
Dainik Navshakti
Morepen Lab carves out its Medical Devices into a Subsidiary
India Infoline
Morepen Labs Forms New Subsidiary For Medical Devices
Medical Dialogues
Morepen Lab shares jump over 8 pc
Outlook India
Morepen Laboratories shares surge 11% on hiving off medical device business
The Free Press Journal
Morepen Labs jumps 11% on transfer of medical devices biz to subsidiary
The Economic Times
मोरपेन लेबोरेटरीज का मुनाफा पहली तिमाही में 57 फीसदी बढ़ा
NavBharat Times
Morepen Laboratories Q1 profit jumps 57% to Rs 30.47 cr
Free Press Journal
Morepen Labs' net revenue up 50 per cent to Rs 388.31 Cr in Q1 FY’22
BioSpectrum India
Morepen Lab gains after Q1 PAT rises 57% YoY
Business Standard
Morepen Laboratories Q1 results: Net profit jumps 57% to Rs 30 cr
The Economic Times
Morepen Laboratories profit jumps
Business Standard (Hindi)
Morepen clocks 57% growth in net profit at Rs 30 crore in June quarter
Dainik Yashobhoomi
Morepen Laboratories profit jumps
The Statesman
Morepen Laboratories profit jumps 57%
The Financial Express (Guj)
Morepen Laboratories Q1 profit jumps 57% to Rs 30.47 cr
Divya Bhaskar
Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine
Satellite Samachar
Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine
Ahmedabad Express
Morepen Lab starts producing Sputnik V
Ahmedabad Mirror
Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine
Financial Express Gujarat
Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine
Business Standard
Morepen Labs starts Test Production of Sputnik V at Himachal facility
Medical Dialogues
India’s Morepen Labs starts production of Russia’s Sputnik V
Telangana Today
Morepen Labs begins trial production of Sputnik V
Live Aaj Tak
RDIF, Morepen Laboratories in partnership for Sputnik V vaccine
BioSpectrum India
Morepen makes 1st test batch of Russia's Sputnik V vaccine
Business Today
Morepen Labs starts production of test batch of Sputnik V vaccine
The New Indian Express
Morepen Labs starts production of test batch of Russia’s Sputnik V COVID-19 vaccine
The Financial Express
Morepen Labs begins trial production of Sputnik V
Punjab Kesari
Sputnik V Vaccine: Morepen Labs commences producing test batch at Himachal facility
The Hindu Business Line
India's Morepen Labs starts production of test batch of Sputnik V vaccine
The Economic Times
Morepen Laboratories posts two-fold jump in Q4 profit
The Economic Times
Morepen Laboratories Q4 net profit rises over two-fold to Rs 27 cr
Business Standard
CMD, Sushil Suri's Interview on CNBC Bazaar
CNBC Bazaar
This smallcap pharma stock has zoomed 101% in a month
Business Standard
Morepen Labs to raise over 433 Crore
Hitavada
Aajkal (Bangla)
Aajkal (Bangla)
Loksatta News
Loksatta
Telegraph: Morepen Cash Course
Telegraph
Morepen Laboratories to raise over Rs 433 Cr
StartupLanes
Morepen Labs Expands POCDx Business
India News Republic
Morepen Laboratories To Raise Over Rs 433 Cr
BW Businessworld Disrupt
Morepen Labs to expand POC Dx business
Express Healthcare
Morepen Labs to raise over Rs 433 cr via issuance of preferential shares
Business Standard
Morepen Group seals ₹750-cr investment from Switzerland-based Corinth Group
Hindu BusinessLine
Board of Morepen Lab approves investment proposed by Corinth Group
Business Standard
Morepen seals Rs 750 crore investment from Corinth Group
Big News Network
Swiss investment firm Corinth bets on Morepen, plans India fund
The Capital Quest
Morepen Group seals Rs 750 Cr investment to expand diagnostic biz
BioSpectrum India
Corinth Group of Switzerland to invest USD 100 million in Morepen Laboratories
Dalal Street Investment Journal
In Morepen's three-and-a-half decade journey, we have always aspired to be an organisation with tangible, visible differences where every individual action is inspired by a deep, humbling desire to make a difference to the lives we touch. Our state-of-art manufacturing facility in the picturesque environs of Baddi comprises a scientifically integrated complex of 10 plants, each with a specific product profile. The company's extensive R&D facilities and factories are manned by a dedicated team of professionals who ensure stringent quality standards. With a strong global presence, Morepen exports to over 75 countries with certifications from all major regulatory authorities like USFDA, WHO GMP, EU GMP. Our domestic products under the brand name, Dr. Morepen and Gubb world have a huge range of healthcare, grooming and OTC products trusted by over 100 million consumers.
“To provide high quality pharmaceutical products of International Standards to generic markets and to promote Innovative health products in India for consumers at large with commitment to quality and service.”
“To create a dynamic and vibrant boutique pharmaceutical company which has a lot of Passion, Pride and Values driven by fundamentals of quality and innovation. To build an organization where everybody has freedom of thought and space to grow and prosper.”
